Literature DB >> 11040958

Cystatin C--properties and use as diagnostic marker.

A O Grubb1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11040958      PMCID： PMC7130541          DOI： 10.1016/s0065-2423(01)35015-1

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN： 0065-2423            Impact factor:   5.394


× No keyword cloud information.
  166 in total

1.  Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy.

Authors:  B Stabuc; L Vrhovec; M Stabuc-Silih; T E Cizej
Journal:  Clin Chem       Date:  2000-02       Impact factor: 8.327

Review 2.  The cystatins: protein inhibitors of cysteine proteinases.

Authors:  V Turk; W Bode
Journal:  FEBS Lett       Date:  1991-07-22       Impact factor: 4.124

3.  Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1).

Authors:  M D Lalioti; M Mirotsou; C Buresi; M C Peitsch; C Rossier; R Ouazzani; M Baldy-Moulinier; A Bottani; A Malafosse; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

4.  Rapid evaluation of creatinine clearance.

Authors:  K Siersbaek-Nielsen; J M Hansen; J Kampmann; M Kristensen
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

5.  In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption.

Authors:  J M Delaissé; Y Eeckhout; G Vaes
Journal:  Biochem Biophys Res Commun       Date:  1984-12-14       Impact factor: 3.575

6.  Skin deposits in hereditary cystatin C amyloidosis.

Authors:  E Benedikz; H Blöndal; G Gudmundsson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

7.  Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system.

Authors:  H Löfberg; A O Grubb
Journal:  Scand J Clin Lab Invest       Date:  1979-11       Impact factor: 1.713

8.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases.

Authors:  G Salvesen; C Parkes; M Abrahamson; A Grubb; A J Barrett
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

9.  Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor.

Authors:  J P Freije; M Abrahamson; I Olafsson; G Velasco; A Grubb; C López-Otín
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

10.  Evidence for the interaction of valine-10 in cystatin C with the S2 subsite of cathepsin B.

Authors:  P Lindahl; D Ripoll; M Abrahamson; J S Mort; A C Storer
Journal:  Biochemistry       Date:  1994-04-12       Impact factor: 3.162
View more
  79 in total

1.  Apoptotic cell death and microglial cell responses in cultured rat retina.

Authors:  Karl Engelsberg; Berndt Ehinger; Johan Wassélius; Kjell Johansson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-27       Impact factor: 3.117

2.  Clinical Relevance of Differences in Glomerular Filtration Rate Estimations in Frail Older People by Creatinine- vs. Cystatin C-Based Formulae.

Authors:  Anne Jacobs; Carolien Benraad; Jack Wetzels; Marcel Olde Rikkert; Cornelis Kramers
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

Review 3.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

4.  Prevention of amyloid fibril formation of amyloidogenic chicken cystatin by site-specific glycosylation in yeast.

Authors:  Jianwei He; Youtao Song; Nobuhiro Ueyama; Akira Saito; Hiroyuki Azakami; Akio Kato
Journal:  Protein Sci       Date:  2006-02       Impact factor: 6.725

5.  Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.

Authors:  Michael Zappitelli; Jason H Greenberg; Steven G Coca; Catherine D Krawczeski; Simon Li; Heather R Thiessen-Philbrook; Michael R Bennett; Prasad Devarajan; Chirag R Parikh
Journal:  JAMA Pediatr       Date:  2015-06       Impact factor: 16.193

Review 6.  Marking renal injury: can we move beyond serum creatinine?

Authors:  Jessica L Slocum; Michael Heung; Subramaniam Pennathur
Journal:  Transl Res       Date:  2012-02-03       Impact factor: 7.012

7.  Arsenic exposure, inflammation, and renal function in Bangladeshi adults: effect modification by plasma glutathione redox potential.

Authors:  Brandilyn A Peters; Xinhua Liu; Megan N Hall; Vesna Ilievski; Vesna Slavkovich; Abu B Siddique; Shafiul Alam; Tariqul Islam; Joseph H Graziano; Mary V Gamble
Journal:  Free Radic Biol Med       Date:  2015-04-24       Impact factor: 7.376

8.  Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula.

Authors:  Christopher I Esezobor; Edna Iroha; Olajumoke Oladipo; Elizabeth Onifade; Oyetunji O Soriyan; Adebola O Akinsulie; Edamisan O Temiye; Chinyere Ezeaka
Journal:  J Int AIDS Soc       Date:  2010-05-18       Impact factor: 5.396

9.  The impact of demographic characteristics and lifestyle in the distribution of cystatin C values in a healthy greek adult population.

Authors:  Angelos A Evangelopoulos; Natalia G Vallianou; Vassiliki P Bountziouka; Amalia N Giotopoulou; Maria S Bonou; John Barbetseas; Peter C Avgerinos; Demosthenes B Panagiotakos
Journal:  Cardiol Res Pract       Date:  2010-10-14       Impact factor: 1.866

10.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.